한글목차

나노바디의 동향과 전망

세계 나노체 시장은 2024년부터 2030년까지 연평균 24.7%의 성장률로 2030년까지 약 28억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정밀의료에 대한 관심 증가와 나노바디 연구 개발에 대한 지원 증가입니다. 세계 나노체 시장의 미래는 치료, 진단 및 연구 시장에서의 기회로 인해 유망합니다.

나노바디 시장 인사이트

Lucintel의 예측에 따르면, 다양한 암종의 존재감이 높아짐에 따라 예측 기간 동안 모노특이적 나노체는 높은 성장세를 보일 것으로 예상됩니다.

이 시장 중 연구 분야는 제약회사들의 나노바디 채택 증가로 인해 가장 큰 시장으로 남아 있습니다.

북미는 나노바디 기술과 관련된 높은 인지도로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 규모는?

A1. 세계 나노바디 시장은 2030년까지 약 28억 달러에 달할 것으로 예상됩니다.

Q2. 시장 성장 전망은?

A2. 세계 나노바디 시장은 2024년부터 2030년까지 연평균 24.7%의 성장률을 나타낼 것으로 예상됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A3.이 시장의 주요 촉진요인은 정밀의료에 대한 관심 증가와 나노바디 연구 개발에 대한 지원 증가입니다.

Q4. 시장의 주요 부문은?

A4. 나노체 시장의 미래는 치료, 진단, 연구 시장에 기회가 있고 유망합니다.

Q5. 시장의 주요 기업은?

A5. 주요 나노체 기업은 다음과 같습니다.

• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• 타이쇼제약

Q6. 향후 가장 큰 시장 부문은?

A6.Lucintel의 예측에 따르면, 다양한 유형의 암이 증가함에 따라 예측 기간 동안 모노특이적 나노체는 높은 성장을 이룰 것으로 예상됩니다.

Q7. 향후 5년간 가장 큰 시장으로 성장할 것으로 예상되는 지역은?

A7. 북미는 나노바디 기술과 관련된 높은 인지도로 인해 예측 기간 동안 가장 규모가 큰 지역으로 남을 것입니다.

Q8. 보고서 커스터마이징이 가능한가?

A8. 네. Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 나노바디 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 나노바디 시장 동향(2018-2023)과 예측(2024-2030)
• 유형별
  • Mono-Specific
  • Multi-Specific
• 용도별
  • 치료
  • 진단
  • 연구
• 최종 용도별
  • 제약 및 바이오테크놀러지 기업
  • 연구
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2030년)

• 지역별 나노바디 시장
• 북미의 나노바디 시장
• 유럽의 나노바디 시장
• 아시아태평양의 나노바디 시장
• 기타 지역의 나노바디 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
• 세계 나노바디 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 나노바디 시장 능력 확대
  • 세계 나노바디 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증과 라이선싱

제7장 유력 기업 개요

• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• Taisho Pharmaceutical

영문목차

Nanobody Trends and Forecast

The future of the global nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets. The global nanobody market is expected to reach an estimated $2.8 billion by 2030 with a CAGR of 24.7% from 2024 to 2030. The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

A more than 150-page report is developed to help in your business decisions.

Nanobody by Segment

The study includes a forecast for the global nanobody by type, application, end use, and region.

Nanobody Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Mono-Specific
• Multi-Specific

Nanobody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Therapeutic
• Diagnostic
• Research

Nanobody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical & Biotechnology Companies
• Research Laboratories
• Others

Nanobody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nanobody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nanobody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nanobody companies profiled in this report include-

• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• Taisho Pharmaceutical

Nanobody Market Insights

Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Within this market, research will remain the largest segment due to growing adoption of nanobodies by pharmaceutical companies.

North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Features of the Global Nanobody Market

Market Size Estimates: Nanobody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nanobody market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Nanobody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the nanobody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nanobody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the nanobody market size?

Answer: The global nanobody market is expected to reach an estimated $2.8 billion by 2030.

Q2. What is the growth forecast for nanobody market?

Answer: The global nanobody market is expected to grow with a CAGR of 24.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the nanobody market?

Answer: The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

Q4. What are the major segments for nanobody market?

Answer: The future of the nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets.

Q5. Who are the key nanobody market companies?

Answer: Some of the key nanobody companies are as follows.

• Sanofi
• Merck KGaA
• BIOCYTOGEN
• Proteintech
• Novartis
• GenScript
• Sensei Biotherapeutics
• Beroni
• ExeVir Bio
• Taisho Pharmaceutical

Q6. Which nanobody market segment will be the largest in future?

Answer: Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Q7. In nanobody market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nanobody market by type (mono-specific and multi-specific), application (therapeutic, diagnostic, and research), end use (pharmaceutical & biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nanobody Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nanobody Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nanobody Market by Type
  • 3.3.1: Mono-Specific
  • 3.3.2: Multi-Specific
• 3.4: Global Nanobody Market by Application
  • 3.4.1: Therapeutic
  • 3.4.2: Diagnostic
  • 3.4.3: Research
• 3.5: Global Nanobody Market by End Use
  • 3.5.1: Pharmaceutical & Biotechnology Companies
  • 3.5.2: Research Laboratories
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nanobody Market by Region
• 4.2: North American Nanobody Market
  • 4.2.2: North American Nanobody Market by Application: Therapeutic, Diagnostic, and Research
• 4.3: European Nanobody Market
  • 4.3.1: European Nanobody Market by Type: Mono-Specific and Multi-Specific
  • 4.3.2: European Nanobody Market by Application: Therapeutic, Diagnostic, and Research
• 4.4: APAC Nanobody Market
  • 4.4.1: APAC Nanobody Market by Type: Mono-Specific and Multi-Specific
  • 4.4.2: APAC Nanobody Market by Application: Therapeutic, Diagnostic, and Research
• 4.5: ROW Nanobody Market
  • 4.5.1: ROW Nanobody Market by Type: Mono-Specific and Multi-Specific
  • 4.5.2: ROW Nanobody Market by Application: Therapeutic, Diagnostic, and Research

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nanobody Market by Type
  • 6.1.2: Growth Opportunities for the Global Nanobody Market by Application
  • 6.1.3: Growth Opportunities for the Global Nanobody Market by End Use
  • 6.1.4: Growth Opportunities for the Global Nanobody Market by Region
• 6.2: Emerging Trends in the Global Nanobody Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nanobody Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nanobody Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Sanofi
• 7.2: Merck KGaA
• 7.3: BIOCYTOGEN
• 7.4: Proteintech
• 7.5: Novartis
• 7.6: GenScript
• 7.7: Sensei Biotherapeutics
• 7.8: Beroni
• 7.9: ExeVir Bio
• 7.10: Taisho Pharmaceutical